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Abstract
We compared a fast, single breath-hold three dimensional LGE sequence (3D LGE) with an established two dimensional 
multi breath-hold sequence (2D LGE) and evaluated image quality and the amount of myocardial fibrosis in patients with 
acute and chronic myocarditis. 3D LGE and 2D LGE (both spatial resolution 1.5 × 1.5 mm2, slice-thickness 8 mm, field of 
view 350 × 350 mm2) were acquired in 25 patients with acute myocarditis (mean age 40 ± 18 years, 7 female) and 27 patients 
with chronic myocarditis (mean age 44 ± 22 years, 9 female) on a 1.5 T MR system. Image quality was evaluated by two inde-
pendent, blinded readers using a 5-point Likert scale. Total myocardial mass, fibrotic mass and total fibrotic tissue percentage 
were quantified for both sequences in both groups. There was no significant difference in image quality between 3D und 2D 
acquisitions in patients with acute (p = 0.8) and chronic (p = 0.5) myocarditis. No significant differences between 3D and 2D 
acquisitions could be shown for myocardial mass (acute p = 0.2; chronic p = 0.3), fibrous tissue mass (acute p = 0.7; chronic 
p = 0.1) and total fibrous percentage (acute p = 0.4 and chronic p = 0.2). Inter-observer agreement was substantial to almost 
perfect. Acquisition time was significantly shorter for 3D LGE (24 ± 5 s) as compared to 2D LGE (350 ± 58 s, p < 0.001). In 
patients with acute and chronic myocarditis 3D LGE imaging shows equal diagnostic quality compared to standard 2D LGE 
imaging but with significantly reduced acquisition time.
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Abbreviations
2D  Two dimensional
3D  Three dimensional
ECG  Electrocardiogramm
LGE  Late gadolinium enhancement
LV  Left ventricle/left-ventricular
LVEDV  Left ventricular end-diastolic volume
LVEF  Left ventricular ejection fraction
LVESV  Left ventricular end-systolic volume
LVSV  Left ventricular stroke volume




SSFP  Steady-state free precession
T  Tesla
Introduction
Cardiac magnetic resonance imaging (MRI) has an exclu-
sive role in the noninvasive detection of myocarditis [1]. 
Late gadolinium enhancement (LGE) imaging comprises 
a high sensitivity for the detection of focal fibrotic tissue, 
which can be commonly found in myocarditis [2]. In acute 
myocarditis, clinical presentation and outcome strongly vary, 
ranging from asymptomatic to fulminant myocarditis with 
acute heart failure and even sudden cardiac death [3–5]. It 
has been shown that the presence of myocardial fibrosis has 
diagnostic and prognostic value in patients with acute and 
chronic myocarditis [6–9]. After acute inflammation has 
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declined, residual myocardial scars can persist and trigger 
arrhythmias or cardiovascular complications [10]. Therefore 
diagnosing fibrous tissue is of critical importance, even if 
symptoms of acute myocarditis have already vanished or 
have never occurred in the first place.
Cardiac MRI and especially LGE imaging became a key 
evaluation tool in the challenging diagnosis of myocarditis 
and prognosis estimation. While current guidelines still pro-
pose histological proof as gold standard for diagnosing acute 
myocarditis, endomyocardial biopsy is rarely performed in 
everyday clinical practice [11, 12].
Since CMR is used for risk stratification in patients with 
suspected myocarditis, patients with suspected acute myo-
carditis should be examined as timely as possible [13–15].
However, due to the relatively long CMR acquisition 
times and often limited availability of examination slots 
in the acute hospital setting, further efforts are required to 
shorten and streamline LGE protocols.
The use of three dimensional (3D), single breath-hold 
acquisition techniques in LGE imaging has been estab-
lished in patients with ischemic scars and cardiomyopathies 
[16–19], offering abbreviated and simplified exams when 
compared to two dimensional (2D) LGE protocols. However, 
the value and utility of 3D LGE remains to be demonstrated 
in patients with myocarditis.
The purpose of this study was the qualitative and quanti-
tative assessment of LGE in patients with acute and chronic 
myocarditis using a single breath-hold 3D LGE versus stand-
ard multiple breath-hold 2D LGE.
Methods
Study population
Between July 2017 and September 2018 58 patients (mean 
age 42 ± 18 years, 16 female) with subepicardial or focal 
midmyocardial fibrosis were included in this retrospective 
study. Six male patients that additionally showed subendo-
cardial or transmural scars suspective of coronary artery 
disease were excluded. Twenty-five of the remaining 52 
patients showed focal T2 hyperintensity accompanying scar 
tissue and presented symptoms of acute myocarditis (chest 
pain, elevated biomarkers, ECG alterations). The remaining 
27 patients were categorized as cases with “chronic myocar-
ditis”, because they displayed scars in subepicardial or focal 
midmyocardial location without edema (“chronic fibrosis”) 
and showed no acute clinical symptoms. This study was 
conducted in accordance to the Declaration of Helsinki and 
its later amendments and was approved by the institutional 
review board. All included patients gave written informed 
consent.
CMR data acquisition
CMR was performed on a 1.5 T MR system (Achieva, 
Philips Healthcare, Best, the Netherlands) using a dedi-
cated 5-channel phased array coil. All data were acquired 
during breath holding in end expiration. After scout and 
reference scans, functional and geometric assessment 
was performed using cine balanced steady- state free 
precession (SSFP) images in standard long- axis geom-
etries (two-, three- and four-chamber view) as well as in 
short-axis orientation covering the entire left ventricle 
(LV) (field of view: 350 × 350  mm2, matrix: 300 × 300, 
repetition time/echo time: 3.0/1.5 ms, in-plane resolu-
tion, 1.5 × 1.5  mm2; number of cardiac phases: 20, sec-
tion thickness: 8  mm). Edema- sensitive black blood 
T2-weighted images with and without fat saturation in five 
short- axis slices were acquired for visualizing myocardial 
edema [20].
2D LGE images covering the entire LV were acquired 
15 min after administration of a bolus of 0.2 mmol of 
gadobutrol (Gadovist; Bayer Schering Pharma, Zurich, 
Switzerland) per kilogram body weight. 2D LGE images 
were acquired in short-axis views by using an inversion 
recovery gradient-echo sequence: field of view: 350 × 350 
 mm2; matrix: 256 × 256; repetition time/echo time: 7.4/4.4; 
inversion time: 190–270 ms (individually optimized with 
a Look-Locker sequence); flip angle: 20°; in-plane reso-
lution: 1.5 × 1.5  mm2; section thickness: 8 mm. 3D LGE 
images were acquired with the following parameters: 
field of view: 350 × 350  mm2; matrix: 256 × 256; repeti-
tion time/echo time: 3.6/1.8; inversion time: 190–270 ms 
(individually optimized with a Look- Locker sequence); 
flip angle: 15°; in-plane resolution: 1.5 × 1.5  mm2; section 
thickness: 8 mm.
2D and 3D LGE sequences were performed in random 
order and the acquisition times for both sequences were 
measured and noted.
CMR data analysis
For all quantitative analyses, commercially available 
software (IntelliSpace Portal, Philips, Version 8.0.3) was 
used. CMR data analysis assessment was performed by an 
experienced radiologist (4 years of experience in cardiac 
imaging), blinded to patient characteristics (Table 1). For 
the acquisition of cardiac volume and function, endocar-
dial contours were drawn in end-systolic and end-diastolic 
short-axis balanced SSFP images excluding papillary mus-
cle. Subjective image quality analysis and quantitative car-
diac MR imaging data analysis of 2D and 3D LGE images 
were performed in random order. For 33 randomly chosen 
The International Journal of Cardiovascular Imaging 
1 3
patients, quantitative analysis of 2D and 3D LGE images 
was repeated by the first reader after 4 months to assess 
intra-observer agreement and by a second reader (3 years 
of experience in cardiac imaging) to assess inter-observer 
agreement.
Image quality scoring
The image quality of each dataset was graded by the same 
two blinded independent readers using a five-point Likert 
scale, in which a score of 1 indicated excellent, a score of 2 
good, a score of 3 moderate, a score of 4 poor and a score 
of 5 nondiagnostic image quality. Reference standard was 
the 2D LGE image. In case of a Likert score greater than 
1 (score: 2–5) the reason for impaired image quality was 
noted and categorized as being due to motion artifacts, inad-
equate myocardial nulling, low contrast/high noise or folding 
artifacts.
Quantitative evaluation
A semi-automatic approach was used to quantify the amount 
of LGE. Endocardial and epicardial contours were manually 
drawn on 2D and 3D LGE images and ROIs were placed in 
hyperenhanced and normal appearing remote myocardium 
by the software and reviewed by the reader. Subsequently, 
the areas of unenhanced and hyperenhanced myocardium 
were automatically segmented by using a full-width at half-
maximum algorithm [21]. After segmentation, myocardial 
and fibrous tissue masses were calculated and the percent-
age of fibrous tissue mass relative to total myocardial LV 
mass was computed. The calculated areas of fibrosis as 
well as myocardial tissue mass were double-checked by the 
reader and focal corrections could be performed manually 
if necessary.
Statistical analyses
Continuous data are expressed as means ± standard devia-
tions, and categoric data are expressed as numbers and 
percentages. Image quality scores of the 2D and 3D data 
sets were compared by using the Wilcoxon signed rank test. 
Two-tailed paired t-tests were used to compare normally dis-
tributed continuous data and the Wilcoxon signed rank was 
used for non-parametric distributed continuous data where 
appropriate. Agreement between the results of the two acqui-
sition techniques regarding total myocardial mass, fibrous 
mass and percentage of fibrous mass was assessed by using 
the Pearson correlation coefficient and Bland–Altman analy-
sis with calculation of the limits of agreement (± 1.96 stand-
ard deviation). Intra- and inter-observer variability were 
assessed by calculating Cohen’s kappa coefficients. Kappa 
coefficients were considered as follows: ‘slight’ < 0.21, ‘fair’ 
0.21–0.4, ‘moderate’ 0.41–0.60, ‘substantial’ 0.61–0.80 and 
‘almost perfect’ 0.81–1.0 [22]. All statistical analyses were 
performed using commercially available software (IBM 
SPSS Statistics, release 25.0; SPSS, Armonk, NY). Statis-




In patients with acute myocarditis, 16 out of 25 (64%) from 
the 3D datasets and 19 out of 25 (76%) from the 2D datasets 
Table 1  Demographic 
characteristics
BMI body mass index, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic 
volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction; values in round brack-







 Sex (male/female) 15/5 17/4 0.6
 Age (years) 40 ± 19 [21–72] 43 ± 17 [17–74] 0.7
 Height (m) 1.77 ± 0.07 [1.68–1.94] 1.75 ± 0.1 [1.6–1.9] 0.3
 Weight (kg) 77.8 ± 12 [59–102] 80.3 ± 17 [56–110] 0.7
 BMI 25 ± 3 [8–30] 26 ± 4 [20–36] 0.3
Left ventricular morphology
 LVEDV (ml, 117–200) 168 ± 47 [114–288] 156 ± 37 [81–215] 0.6
 LVESV (ml, 31–76) 81 ± 41 [38–195] 67 ± 24 [31–117] 0.4
 LVSV (ml, 77–133) 87 ± 18 [57–115] 90 ± 18 [55–115] 0.5
 LVEF (%, > 54) 54 ± 11 [26–69] 58 ± 8 [39–68]] 0.3
 LV mass (g, 51–87) 57 ± 17 [35–111] 52 ± 12 [34–72] 0.5
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had excellent image quality (Likert score: 1) (Figs. 1, 2). 
Average image quality did not vary significantly between 3D 
and 2D acquisitions (1.4 ± 0.6 vs. 1.3 ± 0.5, p = 0.8). Inter-
observer agreement was substantial (κ = 0.76 and 0.71 for 
3D and 2D, respectively). 
In patients with chronic fibrosis, 20 out of 27 (74%) from 
the 3D datasets and 21 out of 27 (78%) from the 2D datasets 
had excellent image quality (Likert score: 1) (Figs. 1 and 3). 
There was no significant difference in average image qual-
ity between 3D and 2D acquisitions (1.3 ± 0.7 vs. 1.2 ± 0.5, 
p = 0.5). Inter-observer agreement was substantial to almost 
perfect (κ = 0.76 and 0.81 for 3D and 2D, respectively).
Poor (score: 4) or non-diagnostic (score: 5) image 
quality was found in neither acute nor chronic datasets. 
Impaired image quality (Likert score 2 and 3) occurred 
most frequently due to inadequate myocardial nulling and 




There were no significant differences between 3D and 
2D acquisitions for myocardial mass (111.9 g ± 33.7 vs. 
111.4 g ± 34.1, p = 0.2), fibrous tissue mass (9.2 g ± 5.3 vs. 
9.2 g ± 5.2, p = 0.7) and total fibrous percentage (8.3% ± 4.8 
vs. 8.2% ± 4.6, p = 0.4) (Table 2) with substantial inter-
observer agreement (κ = 0.84, 0.76 and 0.74, respectively) 
and intra-observer agreement (κ = 0.82, 0.80 and 0.79, 
respectively).
A significant correlation was found between 3D and 2D 
datasets for myocardial mass (r = 0.91, p = 0.001), fibrous 
tissue mass (r = 0.99, p = 0.001) and total fibrous percentage 
(r = 0.95, p = 0.001). Bland–Altman analysis showed good 
agreement between 3D and 2D datasets for myocardial mass 
(mean difference: − 0.49 g; limits of agreement: − 4.0 to 
3.51 g), fibrous tissue mass (mean difference: 0.01 g; limits 
of agreement: − 0.8 to 0.81 g) and total fibrous percentage 
(%) (mean difference: 0.07%; limits of agreement: − 0.9 to 
1.1%) (Fig. 4).
Chronic myocarditis
There were no significant differences between 3D and 
2D acquisitions for myocardial mass (108.7 g ± 25.9 vs. 
109.1 g ± 25.8, p = 0.3), fibrous tissue mass (5.1 g ± 4.7 vs. 
5.1 g ± 4.6, p = 0.1) and total fibrous percentage (4.4% ± 4.3 
vs. 4.3% ± 3.1, p = 0.2) (Table 2) with substantial or almost 
perfect inter-observer agreement (κ = 0.75, 0.81 and 0.70, 
respectively) and intra-observer agreement (κ = 0.78, 0.83 
and 0.81, respectively).
A significant correlation was found between 3D and 2D 
datasets for myocardial mass (r = 0.97, p < 0.001), fibrous 
tissue mass (r = 0.96, p < 0.001) and total fibrous percentage 
(r = 0.96, p = 0.001). Bland–Altman analysis showed good 
agreement between 3D and 2D datasets for myocardial mass 
Fig. 1  Upper part: Image 
quality of 3D and 2D LGE 
datasets of patients with acute 
myocarditis and chronic inflam-
matory scars assessed on a 
5- point Likert scale from 1 
(= excellent image quality) to 5 
(= non-diagnostic). Lower part: 
Short-axis 3D LGE images of 
three different patients with 
epicardial fibrosis (arrowheads). 
Left image demonstrates excel-
lent image quality (= 1), middle 
image good image quality 
(= 2, subtle motion artifacts) 
and right image moderate 
image quality (= 3, inadequate 
myocardial nulling, fibrosis still 
detectable). Poor (score: 4) or 
non-diagnostic (score: 5) image 
quality was found in neither 
acute nor chronic datasets
The International Journal of Cardiovascular Imaging 
1 3
(mean difference: 0.31 g; limits of agreement: − 3.13 to 
3.75 g), fibrous tissue mass (mean difference: 0.04 g; limits 
of agreement: − 0.34 to 0.25 g) and total fibrous percent-
age (mean difference: 0.05%; limits of agreement: − 0.34 to 
0.3%) (Fig. 4).
Acquisition time
Acquisition time was significantly shorter for 3D LGE 
(24 ± 5 s) as compared to 2D LGE (350 ± 58 s, p < 0.001).
Discussion
This study compared a fast, single breath-hold 3D LGE 
imaging sequence with a clinically established multi breath-
hold 2D LGE sequence in patients with acute and chronic 
myocarditis. In both groups 3D LGE showed equivalent 
image quality and quantitative information in comparison 
with the 2D LGE sequence but with significantly reduced 
acquisition time. Single breath-hold 3D LGE imaging has 
been established for ischemic scars and cardiomyopathies, 
providing comparable image quality to multi breath-hold 2D 
LGE [18, 23, 24].
Fig. 2  Short-axis LGE CMR images of a 23-year-old male patient 
with acute myocarditis. The upper panel shows basal, midventricular 
and apical sections from 3D LGE acquisition, the middle panel shows 
the same slices from 2D LGE acquisition and the lower panel shows 
the same slices in a T2 weighted sequence. High signal intensity in 
LGE images (arrowheads) indicating epicardial fibrous tissue in basal 
and midventricular anterolateral/inferolateral segments as well as api-
cal lateral segment could be noted in both acquisitions with concomi-
tant hyperintense signal in T2-weighted images
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However, fibrosis in inflammatory disease has lower 
signal intensity compared with ischemic scars, with 
usually smaller amounts of fibrotic tissue in typically sub-
epicardial location and lack of concomitant wall motion 
abnormalities [25, 26]. Optimal image quality of LGE 
images is of utmost importance in order not to miss these 
subtle areas of fibrosis and the established multi breath-
hold 2D LGE sequences are still preferably used in myo-
carditis protocols [27–29].
All fibrotic areas in patients with acute and chronic myo-
carditis in 2D LGE were visible in 3D LGE. In patients with 
acute and chronic myocarditis image quality in 3D datasets 
was comparable to 2D datasets and inter-observer agree-
ment was substantial to almost perfect. Impaired image qual-
ity was mostly due to inadequate myocardial nulling and 
occurred with same frequency in 3D and 2D datasets.
Quantitative LGE evaluation between 3D and 2D data-
sets in both patient groups showed no significant differences 
with substantial to almost perfect inter- and intra-observer 
Fig. 3  Short-axis LGE CMR images of a 47-year-old male patient 
with chronic myocarditis. The upper panel shows basal, midventricu-
lar and apical sections from 3D LGE acquisition, the middle panel 
shows the same slices from 2D LGE acquisition and lower panel 
shows the same slices in a T2 weighted sequence. High signal inten-
sity in LGE images (arrowheads) indicating epicardial fibrous tissue 
in basal and midventricular inferior segments could be noted in both 
acquisitions with no signal alterations in T2-weighted images
Table 2  Quantitative measurements
3D 2D p-values
Acute
 Myocardial mass (g) 111.9 ± 33.7 111.4 ± 34.1 0.2
 Fibrous tissue mass (g) 9.2 ± 5.3 9.2 ± 5.2 0.7
 Total fibrous percentage (%) 8.3 ± 4.8 8.2 ± 4.6 0.4
Chronic
 Myocardial mass (g) 108.7 ± 25.9 109.1 ± 25.8 0.3
 Fibrous tissue mass (g) 5.1 ± 4.7 5.1 ± 4.6 0.1
 Total fibrous percentage (%) 4.4 ± 4.3 4.3 ± 4.1 0.2
Acquisition time (s) 24 ± 5 350 ± 58 < 0.001
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agreement, even though some patients—especially those 
with chronic inflammatory scars—had subtle LGE areas 
with very low scar burden.
For a short-axis one breath-hold 3D LGE sequence 
acquisition time was approximately 24  s compared to 
nearly 6 min for a multi breath-hold 2D acquisition, this 
is a time reduction of more than 90%. Reduced scan time 
serves patient comfort and is economically favorable, 
especially in regard to patients that will receive follow-up 
MRIs. Moreover, if image quality of LGE is low, e.g. due 
Fig. 4  Bland–Altmann plots depicting the mean difference between 
3D and 2D acquisitions and corresponding limits of agreement 
(± 1.96 standard deviation; dotted lines) for myocardial mass, fibrous 
mass, and fibrous percentage in patients with acute (right) and 
chronic myocarditis (left)
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to wrong inversion time, 3D LGE can easily be repeated 
without significantly prolonging overall exam times.
Some limitations have to be mentioned. 2D LGE was 
considered the reference standard for qualitative and quan-
titative LGE evaluation, but histological proof of LGE areas 
was not conducted. LGE appearance (subepicardial or focal 
midmyocardial fibrosis) in 2D LGE and T2-weighted image, 
respectively, was the main criterion for study inclusion and 
patients with a history of ischemic heart disease or other 
non-ischemic cardiomyopathies have not been explicitly 
excluded.
In conclusion, single breath-hold 3D LGE shows equal 
diagnostic quality in acute and chronic inflammatory scars 
compared to standard 2D LGE imaging at significantly 
reduced acquisition time. Therefore, single breath-hold 3D 
LGE can be used instead of multi breath-hold 2D LGE in 
patients with acute and chronic myocarditis.
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